Pharmacoeconomics of pneumonia

American Journal of Surgery

Volumn 179, Issue 2 SUPPL. 1, 2000, Pages 51-57

  Wunderink, Richard G ^a  

^a Physicians Research Network   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTIFICIAL VENTILATION; CONFERENCE PAPER; COST BENEFIT ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DRUG EFFICACY; INFECTION RISK; OUTCOMES RESEARCH; PNEUMONIA; PRIORITY JOURNAL;

EID: 0034058497     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(00)00314-7     Document Type: Conference Paper

References (38)

1. Fagon J.Y., Chastre J., Trouillet J.L., et al. Evaluation of patients suspected of having nosocomial pneumonia are invasive procedures necessary for accurate decision making? Am Rev Respir Dis. 137:1988;A219. Abstract.
2. Niederman M.S., Torres A., Summer W. Invasive diagnostic testing is not needed routinely to manage suspected ventilator-associated pneumonia. Am J Respir Crit Care Med. 150:1994;565-569.
3. Efficacy and toxicity of single daily doses of amikacin and ceftriaxone versus multiple daily doses of amikacin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med. 119:1993;584-593.
4. Schentag J.J. Antibiotic dosing - does one size fit all? JAMA. 279:1998;159-160.
5. Hyatt J.M., Luzier A.B., Forrest A., et al. Modeling the response of pneumonia to antimicrobial therapy. Antimicrob Agents Chemother. 41:1997;1269-1274.
6. Meyer K.S., Urban C., Eagan J.A., et al. Nosocomial outbreak of klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med. 119:1993;353-358.
7. Alvarez-Lerma F. Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. Intens Care Med. 22:1996;387-394.
8. Torres A., Aznar R., Gatell J.M., et al. Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 142:1990;523-528.
9. Torres A., Aznar R., Gatell J.M., et al. Incidence, risk factors, and prognostic factors of nosocomial pneumonia in mechanically ventilated patients. Am Rev Respir Dis. 142:1990;523-528.
10. Wunderink R.G. Attributable mortality of ventilator-associated pneumonia. Sepsis. 1:1998;211-221.
11. Garrard C.S., A'Court C.D. The diagnosis of pneumonia in the critically ill. Chest. 108:(suppl):1995;17S-25S.
12. Montravers P., Fagon J.Y., Chastre J., et al. Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia. Am Rev Respir Dis. 147:1993;38-44.
13. Rahal J.J., Urban C., Horn D., et al. Class restriction of cephalosporin use to control total cephalosporin resistance in nosocomial klebsiella. JAMA. 280:1998;1233-1237.
14. Kolleff M.H., Bock K.R., Richards R.D., Hearns M.L. The safety and diagnostic accuracy of minibronchoalveolar lavage in patients with suspected ventilator-associated pneumonia. Ann Intern Med. 122:1995;743-748.
15. Fagon J.Y., Chastre J., Hance A.J., et al. Detection of nosocomial lung infection in ventilated patients use of a protected specimen brush and quantitative culture techniques in 147 patients . Am Rev Respir Dis. 138:1988;110-116.
16. Pugazhenti M., Leeper K., Wunderink R., et al. A comparison of nonquantitative endotracheal aspirate (NQ-ETA) and PSB/BAL cultures in the diagnosis of VAP. Am J Respir Crit Care Med. 157:1998;A293.
17. Bonten M.J.M., Bergmans D.C.J., Stobberingh E.E., et al. Implementation of bronchoscopic techniques in the diagnosis of ventilator-associated pneumonia to reduce antibiotic use. Am J Respir Crit Care Med. 156:1997;1820-1824.
18. Baker A.M., Meredith J.W., Haponik E.F. Pneumonia in intubated trauma patients microbiology and outcomes . Am J Respir Crit Care Med. 153:1996;343-349.
19. Kirtland S.H., Corley D.E., Winterbauer R.H., et al. The diagnosis of ventilator-associated pneumonia a comparison of histologic, microbiologic, and clinical criteria . Chest. 112:1997;445-457.
20. Croce M.A., Fabian T.C., Shaw B., et al. Analysis of charges associated with diagnosis of nosocomial pneumonia can routine bronchoscopy be justified? J Trauma. 37:1994;721-727.
21. Heyland D.K., Cook D.J., Marshall J., et al. The clinical utility of invasive diagnostic techniques in the setting of ventilator-associated pneumonia. Chest. 115:1999;1076-1084.
22. Peery C., Chendrasekhar A., Moorman D.W., Timberlake G.A. Non-bronchoscopic protected specimen brushing (PSB) versus tracheal aspirate an evaluation of outcomes . Chest. 114:1998;272S.
23. Fagon J.-Y., Chastre J. Comparison of two diagnostic strategies in patients with a clinical suspicion of ventilator-associated pneumonia (VAP). Am J Respir Crit Care Med. 159:1999;A518. Abstract.
24. Sanchez-Nieto J.M., Torres A., Garcia-Cordoba F., et al. Impact of invasive and noninvasive quantitative culture sampling on outcome of ventilator-associated pneumonia a pilot study . Am J Respir Crit Care Med. 157:1998;371-376.
25. Timsit J.F., Misset B., Renaud B., et al. Effect of previous antimicrobial therapy on the accuracy of the main procedures used to diagnose nosocomial pneumonia in patients who are using ventilation. Chest. 108:1995;1036-1040.
26. Hospital-acquired pneumonia in adults diagnosis, assessment of severity, initial antimicrobial therapy, and preventative strategies: a consensus statement . Am J Respir Crit Care Med. 153:1995;1711-1725.
27. Luna C.M., Vujacich P., Niederman M.S., et al. Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia. Chest. 111:1997;676-685.
28. Kollef M.H., Ward S. The influence of mini-BAL cultures on patient outcomes implications for the antibiotic management of ventilator-associated pneumonia . Chest. 113:1998;412-420.
29. Rodriguez de Castro F., Sole-Violan J., Leon A.A., et al. Do quantitative cultures of protected brush specimens modify the initial empirical therapy in ventilated patients with suspected pneumonia? Eur Respir J. 9:1996;37-41.
30. Fagon J.Y., Chastre J., Hance A.J., et al. Nosocomial pneumonia in ventilated patients a cohort study evaluating attributable mortality and hospital stay . Am J Med. 94:1993;281-299.
31. Rello J., Ausina V., Ricart M., et al. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest. 104:1993;1230-1235.
32. Sterling T.R., Ho E.J., Brehm W.T., Kirkpatrick M.B. Diagnosis and treatment of ventilator-associated pneumonia - impact on survival. Chest. 110:1996;1025-1034.
33. Trouillet J.-L., Chastre J., Vuagnat A., et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 157:1998;531-539.
34. Kollef M.H., Vlasnik J., Sharpless L., et al. Scheduled change of antibiotic classes a strategy to decrease the incidence of ventilator-associated pneumonia . Am J Respir Crit Care Med. 156:1997;1040-1048.
35. Meduri G.U., Mauldin G.L., Wunderink R.G., et al. Causes of fever and pulmonary densities in patients with clinical manifestations of ventilator-associated pneumonia. Chest. 106:1994;221-225.
36. Fink M.P., Snydman D.R., Niederman M.S., et al. Treatment of severe pneumonia in hospitalized patients results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem/cilastatin . Antimicrob Agents Chemother. 38:1994;547-557.
37. Brun-Buisson C., Sollet J.P., Schweich H., et al. Treatment of ventilator-associated pneumonia with piperacillin-tazobactam amikacin versus cetazidime/amikacin a multicenter, randomized controlled trial . Clin Infect Dis. 26:1998;346-354.
38. Cometta A., Baumgartner J.D., Lew D., et al. Prospective randomized comparison of imipenem monotherapy with imipenem plus netilmicin for treatment of severe infections in nonneutropenic patients. Antimicrob Agents Chemother. 38:1994;1309-1313.